A Prospective Study to Evaluate Peginterferon in Reducing the Incidence of HCC in CHB Patients

Clinical trial NCT05671315 · UNKNOWN

Trial details

NCT number: NCT05671315
Sponsor: Qing XIe
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Chronic Hepatitis B Intermediate to High Risk of HCC

Start date: 2019-07-03
Primary completion: 2023-08-01
Enrollment: 267

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.